Interestingly, we found that frequency of CD38 on CD8+ cytotoxic T cells or on monocytes/macrophages was significantly higher in treatment-naïve SCLC samples as compared to normal tissues or treatment-naïve lung adenocarcinoma (Figure 1B). This evidence concerns the gene CD38 and lung adenocarcinoma.